{"id":"week-36","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, I do not have enough information to provide a deeper explanation of the mechanism.","oneSentence":"Week 36 drug is used to treat various conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:41:01.252Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Various conditions"}]},"trialDetails":[{"nctId":"NCT02466971","phase":"PHASE3","title":"Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-05-10","conditions":"Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma","enrollment":450},{"nctId":"NCT04669158","phase":"PHASE1, PHASE2","title":"Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-07-30","conditions":"Non Alcoholic Steatohepatitis, Fibrosis","enrollment":53},{"nctId":"NCT04404881","phase":"PHASE2","title":"Bevacizumab In Hereditary Hemorrhagic Telangiectasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hanny Al-Samkari, MD","startDate":"2020-11-23","conditions":"Hereditary Hemorrhagic Telangiectasia","enrollment":33},{"nctId":"NCT07495709","phase":"","title":"Reactions to Oro-facial Solicitations : a Predictor of Eating Difficulties for Premature Babies of 36 Weeks Gestation Adjusted Age","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2026-04-01","conditions":"Premature","enrollment":80},{"nctId":"NCT06196879","phase":"PHASE2","title":"A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)","status":"COMPLETED","sponsor":"Upstream Bio Inc.","startDate":"2024-02-27","conditions":"Severe Asthma","enrollment":479},{"nctId":"NCT01396408","phase":"PHASE2","title":"A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2012-02-09","conditions":"Advanced Rare Tumours","enrollment":137},{"nctId":"NCT06551506","phase":"PHASE4","title":"The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-09-19","conditions":"Respiratory Syncytial Virus Infection","enrollment":181},{"nctId":"NCT06770582","phase":"PHASE2","title":"Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-03","conditions":"Non-Muscle Invasive Bladder Urothelial Carcinoma, Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v8","enrollment":160},{"nctId":"NCT07498790","phase":"NA","title":"Equal-Volume Pilates Frequency in Women With Overweight and Obesity","status":"COMPLETED","sponsor":"Pamukkale University","startDate":"2023-09-11","conditions":"Overweight and Obesity","enrollment":51},{"nctId":"NCT00001309","phase":"PHASE1","title":"The Body's Affect on Vitamin C","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1997-01-23","conditions":"Healthy Volunteers","enrollment":23},{"nctId":"NCT06059872","phase":"NA","title":"Biomarkers of Reaction To HIIT Exercise","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-01-01","conditions":"Stroke, Stroke Rehabilitation, Lower Extremity Weakness, Spastic","enrollment":55},{"nctId":"NCT03871257","phase":"PHASE3","title":"A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-01-15","conditions":"Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma","enrollment":165},{"nctId":"NCT06554665","phase":"NA","title":"Powering Up Stroke Rehabilitation Through HIIT","status":"RECRUITING","sponsor":"The Hong Kong Polytechnic University","startDate":"2024-08-20","conditions":"Stroke","enrollment":66},{"nctId":"NCT06732245","phase":"PHASE2","title":"Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese","status":"NOT_YET_RECRUITING","sponsor":"Biomed Industries, Inc.","startDate":"2026-08-15","conditions":"Obesity and Overweight","enrollment":224},{"nctId":"NCT05099003","phase":"PHASE1, PHASE2","title":"A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-05-31","conditions":"Malignant Glioma","enrollment":132},{"nctId":"NCT07493603","phase":"PHASE1, PHASE2","title":"A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease","status":"RECRUITING","sponsor":"Xia Liang","startDate":"2026-01-16","conditions":"Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses","enrollment":30},{"nctId":"NCT04185402","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2021-05-29","conditions":"Trachoma","enrollment":3931},{"nctId":"NCT06536296","phase":"NA","title":"The Impact of Music Medicine on Preterm Brain Development and Behavior","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-05-19","conditions":"Infant Development, Language Development, Prematurity","enrollment":243},{"nctId":"NCT03197506","phase":"PHASE2","title":"Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-01-15","conditions":"Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma","enrollment":52},{"nctId":"NCT02615184","phase":"PHASE2","title":"A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeda","startDate":"2023-05-23","conditions":"Erosive Esophagitis","enrollment":76},{"nctId":"NCT06945107","phase":"PHASE3","title":"A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.","startDate":"2025-05-27","conditions":"Plaque Psoriasis","enrollment":308},{"nctId":"NCT06884579","phase":"NA","title":"Educational Programs Based on Healthy Habits to Improve Quality of Life and Psychosocial Profile in Women With Neurodegenerative Diseases: the ADVICE Protocol Study (Phase 2)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad de Almeria","startDate":"2025-04-15","conditions":"Multiple Sclerosis (MS) - Relapsing-remitting","enrollment":60},{"nctId":"NCT04933539","phase":"PHASE2","title":"Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-10-31","conditions":"Multiple Myeloma","enrollment":14},{"nctId":"NCT03458026","phase":"NA","title":"Move Your Spondyl \" Better Live Its Rheumatism With the Physical Activity \"","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2018-03-22","conditions":"Spondyloarthritis","enrollment":108},{"nctId":"NCT07220473","phase":"PHASE2","title":"Tirzepatide to Slow Biological Aging","status":"RECRUITING","sponsor":"The University of Texas Medical Branch, Galveston","startDate":"2026-02-27","conditions":"Aging, LONGEVITY 1","enrollment":90},{"nctId":"NCT03835767","phase":"PHASE2","title":"Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-04-19","conditions":"Milk and/or Peanut Allergy","enrollment":200},{"nctId":"NCT03575897","phase":"NA","title":"Serial Assessment of Body Fat Accrual in Very Preterm Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2018-09-10","conditions":"Infant,Premature, Body Weight, Adiposity","enrollment":50},{"nctId":"NCT05656794","phase":"PHASE2","title":"Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2023-08-09","conditions":"Prostate Metastases","enrollment":40},{"nctId":"NCT04534556","phase":"NA","title":"Wireless Nerve Stimulation Device To Enhance Recovery After Stroke","status":"RECRUITING","sponsor":"Baylor Research Institute","startDate":"2021-09-01","conditions":"Stroke, Chronic Stroke, Upper Extremity Paresis","enrollment":42},{"nctId":"NCT07487259","phase":"","title":"Impact of the Early Life Virome Development on Bronchopulmonary Dysplasia in Preterm Neonates","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-04-01","conditions":"Bronchopulmonary Dysplasia (BPD)","enrollment":40},{"nctId":"NCT03091660","phase":"PHASE3","title":"S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2017-02-24","conditions":"Stage 0 Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma, Stage I Bladder Urothelial Carcinoma","enrollment":1000},{"nctId":"NCT06860542","phase":"PHASE2","title":"Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis","status":"RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2026-02-10","conditions":"Pneumonitis, Immune-related Adverse Event","enrollment":94},{"nctId":"NCT05408832","phase":"PHASE2","title":"Personalized Trials for Stress Management Against Standard of Care","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2022-06-23","conditions":"Stress","enrollment":212},{"nctId":"NCT02138734","phase":"PHASE1, PHASE2","title":"A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer","status":"RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2014-07-21","conditions":"Non-muscle Invasive Bladder Cancer","enrollment":596},{"nctId":"NCT05037279","phase":"PHASE3","title":"Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)","status":"RECRUITING","sponsor":"Verity Pharmaceuticals Inc.","startDate":"2024-04-24","conditions":"Bladder Cancer, Bladder Cancer Recurrent, Neoplasm Recurrence","enrollment":540},{"nctId":"NCT06664229","phase":"NA","title":"Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults","status":"RECRUITING","sponsor":"Sunmi Song","startDate":"2024-01-15","conditions":"Dementia, Mild, Accidental Falls, Mild Cognitive Impairment","enrollment":205},{"nctId":"NCT04938817","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-08-19","conditions":"Small Cell Lung Carcinoma","enrollment":110},{"nctId":"NCT04430699","phase":"PHASE2","title":"Cisplatin+Pembrolizumab+RT in Vulvar Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2020-07-29","conditions":"Vulvar Cancer, Vulvar Squamous Cell Carcinoma","enrollment":24},{"nctId":"NCT07483970","phase":"PHASE1","title":"A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Jecho Biopharmaceuticals Co., Ltd.","startDate":"2026-03-30","conditions":"High Risk Non-muscle Invasive Bladder Cancer","enrollment":18},{"nctId":"NCT01011920","phase":"PHASE2","title":"Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma","status":"COMPLETED","sponsor":"International Extranodal Lymphoma Study Group (IELSG)","startDate":"2009-11","conditions":"Central Nervous System Lymphoma","enrollment":227},{"nctId":"NCT06991257","phase":"PHASE2","title":"A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-06-19","conditions":"Heart Failure","enrollment":620},{"nctId":"NCT03301220","phase":"PHASE3","title":"A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-07","conditions":"Smoldering Multiple Myeloma","enrollment":390},{"nctId":"NCT04571229","phase":"","title":"Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma","status":"AVAILABLE","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"","conditions":"Osteosarcoma","enrollment":""},{"nctId":"NCT04213261","phase":"PHASE3","title":"A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa","status":"ACTIVE_NOT_RECRUITING","sponsor":"Castle Creek Biosciences, LLC.","startDate":"2020-06-09","conditions":"Recessive Dystrophic Epidermolysis Bullosa","enrollment":6},{"nctId":"NCT05813327","phase":"PHASE1","title":"Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-03-14","conditions":"Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue","enrollment":6},{"nctId":"NCT03663933","phase":"PHASE2","title":"Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-09-04","conditions":"Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders","enrollment":71},{"nctId":"NCT05588960","phase":"","title":"Investigating Cerebral Oxygenation in the Newborn","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Edinburgh","startDate":"2023-07-21","conditions":"Hypoxic Ischemic Encephalopathy of Newborn, Neonatal Encephalopathy, Premature Infant Disease","enrollment":99},{"nctId":"NCT05406362","phase":"PHASE1, PHASE2","title":"Assess Safety and Efficacy of VAD044 in HHT Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vaderis Therapeutics AG","startDate":"2022-07-18","conditions":"Hereditary Hemorrhagic Telangiectasia (HHT)","enrollment":75},{"nctId":"NCT02114229","phase":"PHASE2","title":"Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-05-14","conditions":"Malignant Rhabdoid Tumor, Atypical Teratoid Rhabdoid Tumor","enrollment":125},{"nctId":"NCT06075953","phase":"PHASE2","title":"DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment","status":"RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2024-02-17","conditions":"Ductal Carcinoma in Situ","enrollment":400},{"nctId":"NCT05783596","phase":"PHASE2","title":"Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Reid Merryman, MD","startDate":"2023-07-18","conditions":"Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma","enrollment":47},{"nctId":"NCT04452591","phase":"PHASE3","title":"Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin","status":"ACTIVE_NOT_RECRUITING","sponsor":"CG Oncology, Inc.","startDate":"2020-10-27","conditions":"Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer","enrollment":190},{"nctId":"NCT07475741","phase":"NA","title":"Exergaming for Imrpving Upper Limb Functions in Parkinson's Disease","status":"RECRUITING","sponsor":"University of Health Sciences Lahore","startDate":"2026-02-20","conditions":"Parkinsons Disease (PD)","enrollment":30},{"nctId":"NCT05820386","phase":"NA","title":"Skin-to-skin Contact During the Transfer From the Delivery Room to the Neonatal Intensive Care Unit: Impact on Very Preterm Infants and Their Parents","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2023-05-03","conditions":"Skin to Skin, Premature Newborns","enrollment":118},{"nctId":"NCT04936529","phase":"PHASE2","title":"A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-08-02","conditions":"Neuroblastoma","enrollment":286},{"nctId":"NCT03901963","phase":"PHASE3","title":"A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-04-26","conditions":"Multiple Myeloma","enrollment":200},{"nctId":"NCT05451979","phase":"NA","title":"HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-02-22","conditions":"Pediatric ALL, Transplant; Failure, Heart","enrollment":10},{"nctId":"NCT05639556","phase":"","title":"Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2023-04-20","conditions":"Cystic Fibrosis","enrollment":300},{"nctId":"NCT06289647","phase":"PHASE4","title":"Azithromycin Reduction to Reach Elimination of Trachoma B","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2024-10","conditions":"Trachoma","enrollment":""},{"nctId":"NCT06510309","phase":"PHASE2","title":"Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma","status":"RECRUITING","sponsor":"Gottfried von Keudell, MD PhD","startDate":"2026-02-11","conditions":"Lymphoma, Marginal Zone Lymphoma, MZL","enrollment":33},{"nctId":"NCT07466017","phase":"PHASE2","title":"A Study of CS060380 Tablets in Patients With MASH and Obesity","status":"NOT_YET_RECRUITING","sponsor":"Cascade Pharmaceuticals, Inc","startDate":"2026-04-14","conditions":"Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity","enrollment":120},{"nctId":"NCT07465107","phase":"NA","title":"Motor and Cognitive Exercise in Parkinson's Disease.","status":"RECRUITING","sponsor":"Annemette Lokkegaard","startDate":"2025-03-26","conditions":"Parkinson Disease (PD)","enrollment":48},{"nctId":"NCT06202066","phase":"PHASE2","title":"Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2026-04-15","conditions":"Digestive System Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm, Malignant Solid Neoplasm","enrollment":60},{"nctId":"NCT04175678","phase":"NA","title":"Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2020-02-21","conditions":"Healthy Lifestyle, Obese, Men","enrollment":100},{"nctId":"NCT05758480","phase":"NA","title":"Characterization of the Immunometabolic Signature in Long COVID-19.","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2023-05-24","conditions":"Long COVID","enrollment":62},{"nctId":"NCT06685835","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insmed Incorporated","startDate":"2024-12-16","conditions":"Hidradenitis Suppurativa","enrollment":214},{"nctId":"NCT05004896","phase":"PHASE2","title":"Ketamine for Treatment-Resistant Bipolar Disorder","status":"COMPLETED","sponsor":"Joshua Rosenblat","startDate":"2022-07-04","conditions":"Bipolar Disorder, Bipolar Depression, Bipolar I Disorder","enrollment":71},{"nctId":"NCT05130801","phase":"PHASE1, PHASE2","title":"A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-11-19","conditions":"Breast Cancer","enrollment":55},{"nctId":"NCT06200519","phase":"","title":"Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography","status":"ACTIVE_NOT_RECRUITING","sponsor":"University College Cork","startDate":"2024-02-12","conditions":"Diastolic Dysfunction, Neonatal Encephalopathy, Small for Gestational Age at Delivery","enrollment":216},{"nctId":"NCT07448415","phase":"PHASE2, PHASE3","title":"Evaluation of the Efficacy of Oral Tranexamic Acid and Glutathione-assisted Microneedling in Treatment of Melasma","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-02","conditions":"Melasma","enrollment":42},{"nctId":"NCT04288245","phase":"NA","title":"Targeted Plasticity Therapy for Upper Limb Rehabilitation in Spinal Cord Injuries","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor Research Institute","startDate":"2021-02-15","conditions":"Spinal Cord Injuries, Upper Extremity Paresis","enrollment":20},{"nctId":"NCT07369752","phase":"NA","title":"Enhancing Brain And Mental Health Through Breathing Practice","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-02-19","conditions":"Depressive Disorder, Anxiety, Adolescent","enrollment":40},{"nctId":"NCT03133728","phase":"","title":"Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected Infants","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-05-30","conditions":"HIV Infections, Hiv","enrollment":1682},{"nctId":"NCT06561321","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma","status":"RECRUITING","sponsor":"Indiana University","startDate":"2024-10-30","conditions":"Palmoplantar Keratoderma","enrollment":6},{"nctId":"NCT07433751","phase":"NA","title":"Ultrasound Estimation of Fetal Macrosomia at Term: Diagnostic Accuracy Within 24 Hours of Delivery","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Henri Duffaut - Avignon","startDate":"2026-03-01","conditions":"Macrosomia, Fetal Weight","enrollment":285},{"nctId":"NCT07065630","phase":"PHASE2","title":"Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-10-07","conditions":"Head and Neck Cancer, HPV","enrollment":38},{"nctId":"NCT06859268","phase":"PHASE3","title":"A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-03-05","conditions":"Obesity","enrollment":643},{"nctId":"NCT07445763","phase":"","title":"TARSILA Real-World Evidence Study","status":"NOT_YET_RECRUITING","sponsor":"Inova Medical","startDate":"2026-04-30","conditions":"Respiratory Syncytial Virus (RSV), Maternal Immunization, Acute Respiratory Illness (ARI)","enrollment":5000},{"nctId":"NCT07169929","phase":"","title":"Fetal Transverse Thalamic Diameter and Assessment of Gestational Age as a Fetal Growth Parameter Using 2D Ultrasound","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-09-20","conditions":"Fetal Conditions","enrollment":110},{"nctId":"NCT07443397","phase":"PHASE3","title":"Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2025-08-29","conditions":"Whole-Brain Radiotherapy","enrollment":134},{"nctId":"NCT05827081","phase":"PHASE3","title":"Phase IIIb Study of Ribociclib + ET in Early Breast Cancer","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-02-28","conditions":"Early Breast Cancer","enrollment":1400},{"nctId":"NCT06682429","phase":"NA","title":"Telerehabilitation In The Home After Stroke","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-08-22","conditions":"Stroke","enrollment":202},{"nctId":"NCT05538663","phase":"PHASE3","title":"Intravesical BCG vs GEMDOCE in NMIBC","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2023-02-07","conditions":"Non-muscle-invasive Bladder Cancer","enrollment":870},{"nctId":"NCT05289687","phase":"PHASE2","title":"Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL","status":"RECRUITING","sponsor":"Eastern Cooperative Oncology Group","startDate":"2023-05-25","conditions":"T-cell Acute Lymphoblastic Leukemia","enrollment":20},{"nctId":"NCT06847542","phase":"PHASE3","title":"A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-11-27","conditions":"Neovascular Age-related Macular Degeneration","enrollment":250},{"nctId":"NCT07219121","phase":"PHASE4","title":"Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis","status":"RECRUITING","sponsor":"Travere Therapeutics, Inc.","startDate":"2025-10-07","conditions":"Proteinuria, Immunoglobulin A (IgA) Nephropathy, Focal Segmental Glomerulosclerosis","enrollment":20},{"nctId":"NCT07435610","phase":"NA","title":"Acupuncture Therapy for Pediatric Disorders of Gut-Brain Interaction","status":"RECRUITING","sponsor":"Children's Hospital of Orange County","startDate":"2026-01-08","conditions":"Disorders of Gut-brain Interaction","enrollment":96},{"nctId":"NCT06930625","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs","status":"RECRUITING","sponsor":"Debiopharm International SA","startDate":"2025-11-26","conditions":"Acromegaly","enrollment":119},{"nctId":"NCT07435311","phase":"PHASE1","title":"A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma","status":"COMPLETED","sponsor":"R-Pharm","startDate":"2020-06-15","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":118},{"nctId":"NCT07435324","phase":"PHASE3","title":"A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"R-Pharm","startDate":"2024-08-08","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":161},{"nctId":"NCT06788275","phase":"NA","title":"Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria y Biomédica de Alicante","startDate":"2024-11-01","conditions":"Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, Angina (Stable)","enrollment":132},{"nctId":"NCT07433309","phase":"","title":"CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease","status":"NOT_YET_RECRUITING","sponsor":"Nemocnice AGEL Trinec-Podlesi a.s.","startDate":"2026-06-01","conditions":"Sarcopenia, Body Composition, Sarcopenic Obesity","enrollment":128},{"nctId":"NCT04503551","phase":"PHASE3","title":"A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-08-10","conditions":"Diabetic Retinopathy","enrollment":174},{"nctId":"NCT07432425","phase":"NA","title":"Effects of Different Exercise Protocols on Physical and Cognitive Changes in People With Chronic Neck Pain","status":"RECRUITING","sponsor":"Hacettepe University","startDate":"2025-05-01","conditions":"Neck Pain, Chronic Neck Pain","enrollment":21},{"nctId":"NCT02125786","phase":"PHASE2","title":"A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2014-05-07","conditions":"Ependymoma","enrollment":68},{"nctId":"NCT07342582","phase":"","title":"The Rhinovirus Hospitalization and Investigation of Nasal-airway Omics (RHINO) Study","status":"NOT_YET_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-05","conditions":"Rhinovirus","enrollment":670},{"nctId":"NCT05431010","phase":"NA","title":"Efficacy on Walking Ability of Electroacupuncture Therapy in Elderly Patients With Sarcopenia","status":"RECRUITING","sponsor":"The Third Affiliated hospital of Zhejiang Chinese Medical University","startDate":"2022-07-02","conditions":"Sarcopenia","enrollment":120},{"nctId":"NCT06047457","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ipsen","startDate":"2023-09-29","conditions":"Episodic Migraine","enrollment":751},{"nctId":"NCT06409949","phase":"NA","title":"MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2023-06-01","conditions":"Peripheral Arterial Disease","enrollment":60},{"nctId":"NCT06966479","phase":"PHASE2","title":"A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)","status":"RECRUITING","sponsor":"Upstream Bio Inc.","startDate":"2025-05-21","conditions":"Severe Asthma","enrollment":436}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"week 36","genericName":"week 36","companyName":"University Hospital, Ghent","companyId":"university-hospital-ghent","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Week 36 drug is used to treat various conditions. Used for Various conditions.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}